Company Number: 14628519

Analysis Date: 2025-07-29 15:49 UTC

1. Credit Opinion: DECLINE
   Bainbridge Bio Ltd is an early-stage micro-entity with severely negative net assets (£-178,971) and net current liabilities (£-179,396) as of 31 January 2024. The current liabilities significantly exceed current assets, indicating liquidity stress and inability to meet short-term obligations without external support. The company has yet to generate operating revenue or build equity, relying heavily on director advances. Without a proven track record, positive cash flow, or strong working capital, extending credit would pose a high risk of default.

2. Financial Strength:
   The balance sheet shows minimal fixed assets (£425) and modest current assets (£52,973) mainly comprising cash or receivables. However, current liabilities of £232,369, likely including director loans and trade payables, outweigh assets. Shareholders’ funds are deeply negative, reflecting accumulated losses or start-up costs. The company’s financial position is fragile, with no cushion to absorb shocks. The micro-entity status and short operating history limit transparency and predictive value of financial data.

3. Cash Flow Assessment:
   Net current liabilities indicate negative working capital, implying ongoing cash flow deficits. Director loans of £8,565 suggest reliance on related party funding to support liquidity. There is no indication of operational cash inflows yet, and the company’s ability to generate sustainable cash flow remains unproven. Immediate liquidity risk is elevated, and without additional capital injection or revenue generation, the company cannot be expected to service debt or finance operations independently.

4. Monitoring Points:

• Future annual accounts for evidence of revenue generation and profitability improvement.
• Changes in working capital structure, especially reductions in current liabilities and improvement in net current assets.
• Director advances and related party transactions for signs of financial support or possible risks.
• Cash flow statements and liquidity ratios when available to assess operational cash generation.
• Any material changes in management or business strategy that could impact financial stability.